US Surgical Procedures Market worth 122,881.5 thousand procedures by 2027 - Exclusive Report by MarketsandMarkets™

 "US Surgical Procedures Market by Type (Gastrointestinal, Cardiovascular, Dental, Cosmetic, Urologic, Ophthalmic, Orthopedic, ENT, Gynecologic Surgical Procedures), Channel (Physician Offices, Hospitals, (Inpatient, Outpatient), ASC) - Forecast to 2027", published by MarketsandMarkets™, the US surgical procedures market is projected to reach 122,881.5 thousand procedures by 2027 from 105,814.5 thousand procedures in 2022, at a CAGR of 3.0% during the forecast period.

Browse in-depth TOC on "US Surgical Procedures Market"
20 – Tables
25 – Figures
79 – Pages

Download PDF Brochure-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94756744

Scope of the Report:

The study categorizes the US Surgical Procedures Market based on type and channel.

US Surgical Procedures Market, by Type

• Gastrointestinal Surgical Procedures
• Cardiovascular Surgical Procedures
• Dental Surgical Procedures
• Cosmetic Surgical Procedures
• Urologic Surgical Procedures
• Ophthalmic Surgical Procedures
• Orthopedic Surgical Procedures
• ENT Surgical Procedures
• Obstetric/Gynecologic Surgical Procedures
• Other Surgical Procedures

Note: Other surgical procedures include procedures targeting the nervous system, the endocrine system, and the integumentary system.

US Surgical Procedures Market, by Channel

• Physician Offices
• Hospitals
• Inpatient Surgeries
• Outpatient Surgeries
• Ambulatory Surgery Centre

 

The growth of the US surgical procedures market is largely driven by the growing prevalence of chronic diseases, the rising geriatric population, and increased investment in health facilities. On the other hand, stringent regulations and the high cost of medical devices are major restraints in the market.

The emergence of the COVID-19 pandemic has changed the delivery of medical care. The increased pressure due to the growing rate of hospitalization of COVID-19 patients led to the re-profiling of many hospitals and departments for treating patients with COVID-19. Consequently, many elective surgeries were canceled or postponed worldwide to reserve or redirect the available limited capacities and resources (like hospital beds and patient care professionals) toward COVID-19 patient care and to reduce the spread of the virus.

Moreover, from 2019–2020, the procedural volume for all surgeries declined substantially, but it is expected to increase post-pandemic 2021–2022 due to the backlog emerging from this delay. According to a study by Stanford Medicine, after the March 2020 COVID-19 shutdown, nonurgent surgery rates dropped, but within months they bounced back and remained at pre-pandemic levels. There was a 48% decrease in surgical volume during the seven weeks after mid-March when the CMS recommended that hospitals minimize, postpone, or cancel elective surgeries. By July 2020, the nation's hospitals had ramped up surgical operations with improved safety protocols, and surgery rates began to return to their 2019 levels. By the end of the year, the total volume of surgeries was only 10% below the 2019 volume.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=94756744

In 2021, the dental surgical procedures segment accounted for the largest share of this market.

Based on type, the US surgical procedures market is segmented into gastrointestinal surgical procedures, cardiovascular surgical procedures, dental surgical procedures, cosmetic surgical procedures, urologic surgical procedures, ophthalmic surgical procedures, orthopedic surgical procedures, ENT surgical procedures, obstetric/gynecologic surgical procedures, and other surgical procedures. The share of dental surgical procedures segment can be attributed to the increasing awareness of oral care, increasing prevalence of oral diseases, and rising aging population and the associated teeth loss. Common types of dental surgery include:

Root canal: Root canals are the most common type of dental surgery. According to the School of Dental Medicine (US), more than 15 million root canals are performed every year in the US. According to the American Association of Endodontists, root canals have a success rate of over 95%, and, in most cases, they last a lifetime.

Dental implants: Dental implants replace teeth due to decay, disease, oral cancer, or several causes like smoking or alcoholism.

In 2021, the ambulatory surgery center segment accounted for the largest share of this market.

Based on channel, the US surgical procedures market is segmented into physician offices, hospitals, and ambulatory surgery centers. The ambulatory surgery center segment is estimated to grow at the highest CAGR during the forecast period. The preference for ASCs has risen due to their limited hospitalization time, lower costs than hospital outpatient departments (HOPDs), effective postoperative care, limited risk of disease relapse, and faster patient recovery.

The inpatient surgeries segment accounted for the largest share of the US surgical procedures market for hospitals in 2021.

Hospitals are subsegmented into inpatient surgeries and outpatient surgeries. The inpatient surgeries segment accounted the largest share of the US surgical procedures market for hospitals in 2021. Market growth of this segment is attributed to the preference for robotic-assisted surgery, the surge in the geriatric population, the growing incidence of target conditions (such as cardiovascular diseases, neurological disorders, and traumatic injuries), and the introduction of advanced surgical technologies.

Surgical Robots Market worth $14.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

 The Growth in surgical robots market is primarily driven by the advantages of robotic-assisted surgery, technological advancements in surgical robots, the increasing adoption of surgical robots, and increased funding for medical robot research. The companies have a large market spread across various countries in North America, Europe, Asia Pacific, and the Rest of the World.

The global surgical robots market size was valued at USD 6.4 billion in 2021 and is expected to grow at CAGR of 17.6% from 2021 to 2026.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256618532

Scope of the Report

By Product and Service

• Instruments and Accessories
• Robotic Systems
• Services

By Application

• General Surgery
• Gynecological Surgery
• Urological Surgery
• Neurosurgery
• Orthopedic Surgery
• Other Applications

By End User

• Hospitals
• Ambulatory Surgery Centers

By Region

• North America
• US
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe (RoE)
• Asia Pacific
• Japan
• China
• India
• Rest of APAC (RoAPAC)
• RoW

The COVID-19 pandemic has had a devastating global impact on the world's population and economy. The pandemic has put a significant strain on healthcare systems. During this period, healthcare institutions and providers have been instructed to stop performing elective surgical procedures and medical examinations to minimize the possibility of transmission and conserve healthcare resources for COVID-19 patients. The pandemic has led to a temporary ban on elective surgeries across the globe, which resulted in the cancellations of elective surgeries worldwide posing a negative impact on the globe.

Market Segmentation: -

Based on product & service, the surgical robots market is segmented into robotic systems, instruments & accessories, and services. The instruments & accessories segment commanded the largest share of 53.8% of the market in 2020. This segment is also expected to grow at the highest CAGR of 18.2% during the forecast period. The large share and high growth rate of this segment are mainly driven by the recurrent purchase of instruments & accessories instead of robotic systems, which are a one-time investment.

Based on application, the surgical robots market is segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications. The general surgery segment commanded the largest share of 29.5% of the market in 2020. This segment is also projected to register the highest CAGR of 18.2% during the forecast period. Growth in this market segment can be attributed to the increased use of surgical robots in general procedures such as bariatric surgery, Heller myotomy, gastrectomy, hernia repair, cholecystectomy, transoral surgery, and pancreatectomy.

Regional Analysis:

North America dominated the surgical robots market, with a share of 63.6% in 2019, while the Asia Pacific region is expected to register the highest CAGR of 18.5% during the forecast period. The large share of the North American market can be attributed to the availability of funding for R&D in surgical robots in this region and the increasing adoption of surgical robots for pediatric surgeries in Canada and general surgery procedures in the US.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=256618532

Top Key Players:

Some of the prominent players operating in the Surgical robots market are Intuitive Surgical (US), Stryker Corporation (US), Medtronic (Ireland), Smith & Nephew (UK), Zimmer Biomet (US), Asensus Surgical (Transenterix) (US), Corindus Vascular Robotics (US), Renishaw (UK), Auris Health (US), Medrobotics Corporation (US), Think Surgical (US), Verb Surgical (US), OMNIlife Science (US), CMR  Surgical (US), Preceyes BV (Netherlands), China National Scientific Instruments And Materials Corporation (CSIMC) (China), Microsure (Netherlands), Titan Medical (Canada), avateramedical Gmbh (Germany) and Medicaroid Corporation (Japan).

Genomics Market worth $54.4 billion by 2025 - Exclusive Report by MarketsandMarkets™

 "Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) – Global Forecast to 2025", published by MarketsandMarkets™, the global Genomics Product And Service Market is projected to reach USD 54.4 billion by 2025 from USD 22.7 billion in 2020, at a CAGR of 19.0% during the forecast period.

Browse in-depth TOC on "Genomics Market"

114 – Tables
34 – Figures
194 – Pages

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=613

Scope of the Report:

The study categorizes the market into the following segments and subsegments:

Genomics Market, by Product & Service

• Systems & Software
• Consumables
• Services

Genomics Market, by Technology

• Sequencing
• PCR
• Nucleic Acid Extraction and Purification
• Microarray
• Other Technologies

Genomics Market, by Application 

• Drug Discovery and Development
• Diagnostics
• Agriculture and Animal Research
• Other Applications

Genomics Market, by End User

•  Hospitals & Clinics  
• Research Centers and Academic & Government Institutes,
• Pharmaceutical & Biotechnology Companies
• Other End Users

Genomics Market, by Region

• North America
• US
• Canada
• Europe
• UK
• Germany
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• The Middle East and Africa

The major factors driving the growth of this market include the increasing government funding to support genomics projects, the growing incidence of cancer and increasing applications of NGS in cancer research, the entry of new players and start-ups in the genomics product and service market, and the growing application areas of genomics.

The next generation sequencing sub segment accounted for the largest share of the sequencing technology segment in the genomics market in 2019.

Based on technology, the market is segmented into sequencing technologies, PCR, nucleic acid extraction and purification, microarrays, and other technologies. The sequencing segment is further sub segmented into next-generation sequencing (NGS) and other sequencing technologies. In 2019 the next-generation sequencing technology accounted for the largest share of the genomics market. The advantages associated with NGS such as ultra-high-throughput, scalability, and high speed, enable researchers to perform a wide variety of applications, including animal breeding, agriculture, and human genomics. This is one of the major drivers of this segment.

The hospitals and clinics segment accounted for the largest share of the end user segment in the genomics product and service market in 2019.

Based on end users, the genomics market is segmented into hospitals & clinics, research centers and academic & government institutes, pharmaceutical & biotechnology companies, and other end users. In 2019, the hospitals & clinics segment accounted for the largest share of the market. Hospitals & clinics are shifting from traditional genomic testing methods to cost-effective and more sensitive methods, such as whole-exome sequencing, which is a major factor driving the market growth.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=613

The Asia Pacific region is the fastest growing region of the genomics market in 2019.

In 2019, the Asia Pacific region accented for the fastest growing region of the market. It is also estimated to grow at the highest CAGR in the genomics product and service market during the forecast period, mainly due to favorable government support for genomics projects, increasing awareness about newer genomics technologies such as NGS, and expansions of key players to strengthen their presence in the APAC region.

Some of the leading players operating in the genomics product and service market are Illumina, Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), and BGI (China).

Browse Related Reports:

Nucleic Acid Isolation and Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Precision Medicine), End User (Academic) - Global Forecast to 2027

https://www.marketsandmarkets.com/Market-Reports/nucleic-acid-isolation-purification-market-229978287.html

Operating Room Integration Market worth $3.3 billion by 2027 - Exclusive Report by MarketsandMarkets™

 "Operating Room Integration Market by Component (Hardware, Software, Service), Application (General, Orthopedic, & Cardiovascular Surgery), Device (Audio & Video Management, Display, Document Management), End User (Hospital, ASC) - Global Forecast to 2027", published by MarketsandMarkets™, the global Operating Room Integration Market is projected to reach USD USD 3.3 billion by 2027 from an estimated USD 1.9 billion in 2022, at a CAGR of 12.1% during the forecast period.

Browse in-depth TOC on "Operating Room Integration Market"
133 – Tables
33 – Figures
197 – Pages

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160774667

Scope of the Report:

The study categorizes the operating room integration market based on product, type, technology, application, animal type, end user at regional and global level.

Global Operating room integration Market, by Component

•  Introduction
•  Software
• Services

Operating room integration Market, By Device Type

•  Introduction
• Display systems
• Document Management systems
• Audio & Video Management systems
• Other OR Integration devices

Operating room integration Market, By Application

•  Introduction
• General Surgery
• Orthopedic Surgery
• Cardiovascular Surgery
• Neurosurgery
• Thoracic Surgery
• Other Applications

Operating room integration Market, By End User

•  Introduction
• Hospitals
• Ambulatory Surgical Centers and Clinics

Global Operating room integration Market, by Region

• North America
• US
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Rest Of Europe
• Asia Pacific
• Japan
• China
• India
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Rest of LATAM
• Middle East & Africa

The Growth in this OR Integration Market is driven by the growing demand for technologically advanced solutions, the growing number of surgical procedures, rising funding initiatives for improving HCIT infrastructure, and increasing emphasis on cost control and efficiency improvement in hospitals. However, the high setup and operational costs, interoperability issues, and shortage of skilled surgeons in OR integration are expected to restrain market growth to a certain extent.

By component, the software segment accounted for the largest share of the operating room integration market in 2021.

The software segment is estimated to have the largest share by value of the operating room integration market. OR integration software helps streamline surgical workflows by enabling seamless communication between different systems and ensuring the effective and easier operation of these systems, preferably from a single source. Moreover, operating room integration software helps reduce surgical times, improves coordination between healthcare providers, and improves patient safety.

The orthopedic surgery segment is expected to witness the highest growth rate in the operating room integration market, by application.

Based on application, the orthopedic surgery segment is expected to register the highest CAGR during the forecast period. Factors responsible for the growth of this segment are recent technological advancements in robot-assisted orthopedic surgeries, rising preference for minimally invasive surgeries due to benefits in orthopedic applications (such as decreased procedural trauma, faster patient recovery, and decreased hospital stay).

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=160774667

North America dominated the operating room integration market in 2021.

North America accounted for the largest share of the OR Integration market in 2021, followed by Europe and Asia Pacific. The large share of North America in the global market can be attributed to the rising need to curtail healthcare costs, increasing patient preference for minimally invasive surgeries (owing to procedural benefits such as the lower risk of surgical-site infections, decreased patient injuries, and shorter hospitalization times), growing adoption rate of integrated operating rooms among healthcare providers, and the increasing number of ambulatory surgery centers.

Stryker Corporation (US), STERIS Plc (US), Karl Storz SE & Co. KG (Germany), Olympus Corporation (Japan), Getinge AB (Sweden) are the major players in this market. These companies are majorly focusing on the strategies such as agreements, collaborations, partnerships, and service launches in order to remain competitive and further increase their share in the Operating Room/OR Integration Market.